268 related articles for article (PubMed ID: 12810484)
1. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
[TBL] [Abstract][Full Text] [Related]
2. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
Lemstra AW; van Meegen M; Baas F; van Gool WA
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
[TBL] [Abstract][Full Text] [Related]
3. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
Donahue JE; Hanna PA; Hariharan S
Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
[TBL] [Abstract][Full Text] [Related]
4. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
Sáiz A; Marín C; Tolosa E; Graus F
Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
Aksamit AJ
Arch Neurol; 2003 Jun; 60(6):803-4. PubMed ID: 12810481
[No Abstract] [Full Text] [Related]
7. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
Mendez OE; Shang J; Jungreis CA; Kaufer DI
J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
[TBL] [Abstract][Full Text] [Related]
9. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients.
Kenney K; Brechtel C; Takahashi H; Kurohara K; Anderson P; Gibbs CJ
Ann Neurol; 2000 Sep; 48(3):395-8. PubMed ID: 10976650
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
[TBL] [Abstract][Full Text] [Related]
11. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
Blennow K; Lind B; Andersson E; Andreasen N
Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
13. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
Blennow K; Johansson A; Zetterberg H
Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
[TBL] [Abstract][Full Text] [Related]
16. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
[TBL] [Abstract][Full Text] [Related]
17. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
Bernheimer H; Gatterbauer B; Radbauer C; Budka H
Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
[TBL] [Abstract][Full Text] [Related]
18. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.
Zerr I; Schulz-Schaeffer WJ; Giese A; Bodemer M; Schröter A; Henkel K; Tschampa HJ; Windl O; Pfahlberg A; Steinhoff BJ; Gefeller O; Kretzschmar HA; Poser S
Ann Neurol; 2000 Sep; 48(3):323-9. PubMed ID: 10976638
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.
Appleby BS; Appleby KK; Crain BJ; Onyike CU; Wallin MT; Rabins PV
Arch Neurol; 2009 Feb; 66(2):208-15. PubMed ID: 19204157
[TBL] [Abstract][Full Text] [Related]
20. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
